Back to search

Article

Viral delivery of compact CRISPR-Cas12f for <i>in vivo</i> gene editing applications

2024-02-09

Abstract excerpt

Treating human genetic conditions in vivo requires efficient delivery of the CRISPR gene editing machinery to the affected cells and organs. The gene editing field has seen clinical advances with ex vivo therapies and with in vivo delivery to the liver using lipid nanoparticle technology. Adeno-associated virus (AAV) serotypes have been discovered and engineered to deliver genetic material to nearly every organ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b57b7800-3945-54eb-ae5b-9102c3d5591d
DOI
10.1101/2024.02.06.578965
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Viral delivery of compact CRISPR-Cas12f for <i>in vivo</i> gene editing applicationsDOI 10.1101/2024.02.06.578965
Select a neighboring publication to make it the new centre.